| 9YB | Name: | (3~{R})-3-[[1-(2-hydroxyethyl)-5-[(4-methoxynaphthalen-1-yl)methyl]-6,7-dihydro-4~{H}-pyrazolo[4,3-c]pyridin-3-yl]carbonylamino]-3-phenyl-propanoic acid | Formula: | C30 H32 N4 O5 | SMILES: | COc1ccc(CN2CCc3n(CCO)nc(C(=O)N[CH](CC(O)=O)c4ccccc4)c3C2)c5ccccc15 | InChi: | InChI=1S/C30H32N4O5/c1-39-27-12-11-21(22-9-5-6-10-23(22)27)18-33-14-13-26-24(19-33)29(32-34(26)15-16-35)30(38)31-25(17-28(36)37)20-7-3-2-4-8-20/h2-12,25,35H,13-19H2,1H3,(H,31,38)(H,36,37)/t25-/m1/s1 | Definition date: | 2017-08-01 | Last modified: | 2019-03-01 | Release date: | 2019-03-06 | Identifier: | (3~{R})-3-[[1-(2-hydroxyethyl)-5-[(4-methoxynaphthalen-1-yl)methyl]-6,7-dihydro-4~{H}-pyrazolo[4,3-c]pyridin-3-yl]carbonylamino]-3-phenyl-propanoic acid |
|
| AYO | Name: | (4S)-4-[4'-cyclopropyl-5-(2,2-dimethylpropyl)[3,5'-bi-1,2-oxazol]-3'-yl]-6-[(2,4-dichlorophenyl)amino]-6-oxohexanoic acid | Formula: | C26 H29 Cl2 N3 O5 | SMILES: | C(=O)(CC(c2c(c(c1noc(CC(C)(C)C)c1)on2)C3CC3)CCC(O)=O)Nc4ccc(cc4Cl)Cl | InChi: | InChI=1S/C26H29Cl2N3O5/c1-26(2,3)13-17-12-20(30-35-17)25-23(14-4-5-14)24(31-36-25)15(6-9-22(33)34)10-21(32)29-19-8-7-16(27)11-18(19)28/h7-8,11-12,14-15H,4-6,9-10,13H2,1-3H3,(H,29,32)(H,33,34)/t15-/m0/s1 | Definition date: | 2018-12-07 | Last modified: | 2019-03-01 | Release date: | 2019-03-06 | Identifier: | (4S)-4-[4'-cyclopropyl-5-(2,2-dimethylpropyl)[3,5'-bi-1,2-oxazol]-3'-yl]-6-[(2,4-dichlorophenyl)amino]-6-oxohexanoic acid |
|
| DGP | Name: | 2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE | Formula: | C10 H14 N5 O7 P | SMILES: | O=P(O)(O)OCC3OC(n2cnc1c2N=C(N)NC1=O)CC3O | InChi: | InChI=1S/C10H14N5O7P/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(22-6)2-21-23(18,19)20/h3-6,16H,1-2H2,(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6+/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2019-03-01 | Identifier: | 2'-deoxy-5'-guanylic acid |
|
| AVT | Name: | 2-[9-fluoranyl-5-(4-methoxyphenyl)-3-methyl-1-oxidanylidene-pyrimido[4,5-c]quinolin-2-yl]ethanoic acid | Formula: | C21 H16 F N3 O4 | SMILES: | COc1ccc(cc1)c2nc3ccc(F)cc3c4C(=O)N(CC(O)=O)C(=Nc24)C | InChi: | InChI=1S/C21H16FN3O4/c1-11-23-20-18(21(28)25(11)10-17(26)27)15-9-13(22)5-8-16(15)24-19(20)12-3-6-14(29-2)7-4-12/h3-9H,10H2,1-2H3,(H,26,27) | Definition date: | 2017-08-24 | Last modified: | 2019-02-27 | Release date: | 2018-05-09 | Identifier: | 2-[9-fluoranyl-5-(4-methoxyphenyl)-3-methyl-1-oxidanylidene-pyrimido[4,5-c]quinolin-2-yl]ethanoic acid |
|
| HHZ | Name: | [[(2~{R},3~{S},5~{R})-5-[4-azanyl-5-[3-[2-(2-hydroxyethyloxy)ethanoylamino]prop-1-ynyl]pyrrolo[2,3-d]pyrimidin-7-yl]-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate | Formula: | C18 H26 N5 O15 P3 | SMILES: | Nc1ncnc2n(cc(C#CCNC(=O)COCCO)c12)[CH]3C[CH](O)[CH](CO[P](O)(=O)O[P](O)(=O)O[P](O)(O)=O)O3 | InChi: | InChI=1S/C18H26N5O15P3/c19-17-16-11(2-1-3-20-14(26)9-34-5-4-24)7-23(18(16)22-10-21-17)15-6-12(25)13(36-15)8-35-40(30,31)38-41(32,33)37-39(27,28)29/h7,10,12-13,15,24-25H,3-6,8-9H2,(H,20,26)(H,30,31)(H,32,33)(H2,19,21,22)(H2,27,28,29)/t12-,13+,15+/m0/s1 | Definition date: | 2018-12-07 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | [[(2~{R},3~{S},5~{R})-5-[4-azanyl-5-[3-[2-(2-hydroxyethyloxy)ethanoylamino]prop-1-ynyl]pyrrolo[2,3-d]pyrimidin-7-yl]-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate |
|
| XAF | Name: | 2-[4-[2-fluoranyl-5-[3-(6-methylpyridin-2-yl)-1~{H}-pyrazol-4-yl]phenyl]phenyl]sulfonylethanol | Formula: | C23 H20 F N3 O3 S | SMILES: | Cc1cccc(n1)c2n[nH]cc2c3ccc(F)c(c3)c4ccc(cc4)[S](=O)(=O)CCO | InChi: | InChI=1S/C23H20FN3O3S/c1-15-3-2-4-22(26-15)23-20(14-25-27-23)17-7-10-21(24)19(13-17)16-5-8-18(9-6-16)31(29,30)12-11-28/h2-10,13-14,28H,11-12H2,1H3,(H,25,27) | Definition date: | 2019-01-11 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 2-[4-[2-fluoranyl-5-[3-(6-methylpyridin-2-yl)-1~{H}-pyrazol-4-yl]phenyl]phenyl]sulfonylethanol |
|
| G92 | Name: | [4-(6,7-dimethoxyquinazolin-4-yl)piperidin-1-yl]-[4-(trifluoromethyloxy)phenyl]methanone | Formula: | C23 H22 F3 N3 O4 | SMILES: | COc1cc2ncnc(C3CCN(CC3)C(=O)c4ccc(OC(F)(F)F)cc4)c2cc1OC | InChi: | InChI=1S/C23H22F3N3O4/c1-31-19-11-17-18(12-20(19)32-2)27-13-28-21(17)14-7-9-29(10-8-14)22(30)15-3-5-16(6-4-15)33-23(24,25)26/h3-6,11-14H,7-10H2,1-2H3 | Definition date: | 2018-09-07 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | [4-(6,7-dimethoxyquinazolin-4-yl)piperidin-1-yl]-[4-(trifluoromethyloxy)phenyl]methanone |
|
| G9E | Name: | [2-azanyl-4-(trifluoromethyloxy)phenyl]-[4-(7-methoxyquinazolin-4-yl)piperidin-1-yl]methanone | Formula: | C22 H21 F3 N4 O3 | SMILES: | COc1ccc2c(c1)ncnc2C3CCN(CC3)C(=O)c4ccc(OC(F)(F)F)cc4N | InChi: | InChI=1S/C22H21F3N4O3/c1-31-14-2-5-17-19(11-14)27-12-28-20(17)13-6-8-29(9-7-13)21(30)16-4-3-15(10-18(16)26)32-22(23,24)25/h2-5,10-13H,6-9,26H2,1H3 | Definition date: | 2018-09-07 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | [2-azanyl-4-(trifluoromethyloxy)phenyl]-[4-(7-methoxyquinazolin-4-yl)piperidin-1-yl]methanone |
|
| FT7 | Name: | 1-[(2,4-difluorophenyl)methyl]-2,3-dimethyl-N-[(1R)-1-phenylpropyl]-1H-indole-5-carboxamide | Formula: | C27 H26 F2 N2 O | SMILES: | CCC(c1ccccc1)NC(=O)c2ccc4c(c2)c(c(C)n4Cc3c(F)cc(cc3)F)C | InChi: | InChI=1S/C27H26F2N2O/c1-4-25(19-8-6-5-7-9-19)30-27(32)20-11-13-26-23(14-20)17(2)18(3)31(26)16-21-10-12-22(28)15-24(21)29/h5-15,25H,4,16H2,1-3H3,(H,30,32)/t25-/m1/s1 | Definition date: | 2018-04-16 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 1-[(2,4-difluorophenyl)methyl]-2,3-dimethyl-N-[(1R)-1-phenylpropyl]-1H-indole-5-carboxamide |
|
| J4Q | Name: | 4-[(2-methylsulfonylimidazol-1-yl)methyl]-1,3-thiazole | Formula: | C8 H9 N3 O2 S2 | SMILES: | C[S](=O)(=O)c1nccn1Cc2cscn2 | InChi: | InChI=1S/C8H9N3O2S2/c1-15(12,13)8-9-2-3-11(8)4-7-5-14-6-10-7/h2-3,5-6H,4H2,1H3 | Definition date: | 2019-01-24 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 4-[(2-methylsulfonylimidazol-1-yl)methyl]-1,3-thiazole |
|
| J9H | Name: | pentacoordinate Pt(II) compound | Formula: | C17 H18 N3 Pt | SMILES: | CC1=CCc2ccc3ccc(C)[n+]4c3c2N1[Pt]4(C)N.C=C | InChi: | InChI=1S/C14H13N2.C2H2.CH3.H2N.Pt/c1-9-3-5-11-7-8-12-6-4-10(2)16-14(12)13(11)15-9 | Definition date: | 2019-02-12 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 |
|
| JDG | Name: | 2-cyclohexyl-7-methoxy-N-[1-(propan-2-yl)piperidin-4-yl]-8-[3-(pyrrolidin-1-yl)propoxy]-3H-1,4-benzodiazepin-5-amine | Formula: | C31 H49 N5 O2 | SMILES: | C1N(CCC1)CCCOc5c(cc2c(N=C(CN=C2NC3CCN(CC3)C(C)C)C4CCCCC4)c5)OC | InChi: | InChI=1S/C31H49N5O2/c1-23(2)36-17-12-25(13-18-36)33-31-26-20-29(37-3)30(38-19-9-16-35-14-7-8-15-35)21-27(26)34-28(22-32-31)24-10-5-4-6-11-24/h20-21,23-25H,4-19,22H2,1-3H3,(H,32,33) | Definition date: | 2018-08-31 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 2-cyclohexyl-7-methoxy-N-[1-(propan-2-yl)piperidin-4-yl]-8-[3-(pyrrolidin-1-yl)propoxy]-3H-1,4-benzodiazepin-5-amine |
|
| KUV | Name: | 5-amino-N-{5-[(4R,5R)-4-amino-5-fluoroazepan-1-yl]-1-methyl-1H-pyrazol-4-yl}-2-(2,6-difluorophenyl)-1,3-thiazole-4-carboxamide | Formula: | C20 H22 F3 N7 O S | SMILES: | n3(c(c(NC(c2nc(c1c(cccc1F)F)sc2N)=O)cn3)N4CCC(C(F)CC4)N)C | InChi: | InChI=1S/C20H22F3N7OS/c1-29-20(30-7-5-10(21)13(24)6-8-30)14(9-26-29)27-18(31)16-17(25)32-19(28-16)15-11(22)3-2-4-12(15)23/h2-4,9-10,13H,5-8,24-25H2,1H3,(H,27,31)/t10-,13-/m1/s1 | Definition date: | 2019-01-16 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 5-amino-N-{5-[(4R,5R)-4-amino-5-fluoroazepan-1-yl]-1-methyl-1H-pyrazol-4-yl}-2-(2,6-difluorophenyl)-1,3-thiazole-4-carboxamide |
|
| GKZ | Name: | 1-[2-[4-[4-(4-chlorophenyl)-3-methyl-1~{H}-pyrazol-5-yl]-3-oxidanyl-phenoxy]ethyl]piperidin-1-ium-4-carboxamide | Formula: | C24 H28 Cl N4 O3 | SMILES: | Cc1n[nH]c(c2ccc(OCC[NH+]3CCC(CC3)C(N)=O)cc2O)c1c4ccc(Cl)cc4 | InChi: | InChI=1S/C24H27ClN4O3/c1-15-22(16-2-4-18(25)5-3-16)23(28-27-15)20-7-6-19(14-21(20)30)32-13-12-29-10-8-17(9-11-29)24(26)31/h2-7,14,17,30H,8-13H2,1H3,(H2,26,31)(H,27,28)/p+1 | Definition date: | 2018-09-28 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 1-[2-[4-[4-(4-chlorophenyl)-3-methyl-1~{H}-pyrazol-5-yl]-3-oxidanyl-phenoxy]ethyl]piperidin-1-ium-4-carboxamide |
|
| GNK | Name: | (1~{S},5~{R})-8-[2-(4-chlorophenyl)ethyl]-8-azabicyclo[3.2.1]octan-3-one | Formula: | C15 H18 Cl N O | SMILES: | Clc1ccc(CCN2[CH]3CC[CH]2CC(=O)C3)cc1 | InChi: | InChI=1S/C15H18ClNO/c16-12-3-1-11(2-4-12)7-8-17-13-5-6-14(17)10-15(18)9-13/h1-4,13-14H,5-10H2/t13-,14+ | Definition date: | 2018-09-28 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | (1~{S},5~{R})-8-[2-(4-chlorophenyl)ethyl]-8-azabicyclo[3.2.1]octan-3-one |
|
| GNZ | Name: | (1~{S},5~{R})-8-[2-[4-(trifluoromethyl)phenyl]ethyl]-8-azabicyclo[3.2.1]octan-3-one | Formula: | C16 H18 F3 N O | SMILES: | FC(F)(F)c1ccc(CCN2[CH]3CC[CH]2CC(=O)C3)cc1 | InChi: | InChI=1S/C16H18F3NO/c17-16(18,19)12-3-1-11(2-4-12)7-8-20-13-5-6-14(20)10-15(21)9-13/h1-4,13-14H,5-10H2/t13-,14+ | Definition date: | 2018-09-29 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | (1~{S},5~{R})-8-[2-[4-(trifluoromethyl)phenyl]ethyl]-8-azabicyclo[3.2.1]octan-3-one |
|
| GO2 | Name: | 1-(1,3-benzothiazol-2-yl)guanidine | Formula: | C8 H8 N4 S | SMILES: | NC(=N)Nc1sc2ccccc2n1 | InChi: | InChI=1S/C8H8N4S/c9-7(10)12-8-11-5-3-1-2-4-6(5)13-8/h1-4H,(H4,9,10,11,12) | Definition date: | 2018-09-29 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 1-(1,3-benzothiazol-2-yl)guanidine |
|
| GO5 | Name: | (1~{R},5~{S})-9-[2-(4-chlorophenyl)ethyl]-9-azabicyclo[3.3.1]nonan-3-one | Formula: | C16 H20 Cl N O | SMILES: | Clc1ccc(CCN2[CH]3CCC[CH]2CC(=O)C3)cc1 | InChi: | InChI=1S/C16H20ClNO/c17-13-6-4-12(5-7-13)8-9-18-14-2-1-3-15(18)11-16(19)10-14/h4-7,14-15H,1-3,8-11H2/t14-,15+ | Definition date: | 2018-09-29 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | (1~{R},5~{S})-9-[2-(4-chlorophenyl)ethyl]-9-azabicyclo[3.3.1]nonan-3-one |
|
| GO8 | Name: | 8-propan-2-ylsulfanyl-7~{H}-purin-6-amine | Formula: | C8 H11 N5 S | SMILES: | CC(C)Sc1[nH]c2c(N)ncnc2n1 | InChi: | InChI=1S/C8H11N5S/c1-4(2)14-8-12-5-6(9)10-3-11-7(5)13-8/h3-4H,1-2H3,(H3,9,10,11,12,13) | Definition date: | 2018-09-29 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 8-propan-2-ylsulfanyl-7~{H}-purin-6-amine |
|
| GOE | Name: | 1-(6-methylpyridin-2-yl)-3-propyl-urea | Formula: | C10 H15 N3 O | SMILES: | CCCNC(=O)Nc1cccc(C)n1 | InChi: | InChI=1S/C10H15N3O/c1-3-7-11-10(14)13-9-6-4-5-8(2)12-9/h4-6H,3,7H2,1-2H3,(H2,11,12,13,14) | Definition date: | 2018-09-29 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 1-(6-methylpyridin-2-yl)-3-propyl-urea |
|
| GON | Name: | 1-[2-[3-oxidanyl-4-(4-phenyl-1~{H}-pyrazol-5-yl)phenoxy]ethyl]piperidine-4-carboxamide | Formula: | C23 H26 N4 O3 | SMILES: | NC(=O)C1CCN(CCOc2ccc(c(O)c2)c3[nH]ncc3c4ccccc4)CC1 | InChi: | InChI=1S/C23H26N4O3/c24-23(29)17-8-10-27(11-9-17)12-13-30-18-6-7-19(21(28)14-18)22-20(15-25-26-22)16-4-2-1-3-5-16/h1-7,14-15,17,28H,8-13H2,(H2,24,29)(H,25,26) | Definition date: | 2018-10-01 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 1-[2-[3-oxidanyl-4-(4-phenyl-1~{H}-pyrazol-5-yl)phenoxy]ethyl]piperidine-4-carboxamide |
|
| GUK | Name: | 6-chloranyl-3-(2~{H}-indazol-5-yl)-~{N}-propan-2-yl-imidazo[1,2-b]pyridazin-8-amine | Formula: | C16 H15 Cl N6 | SMILES: | CC(C)Nc1cc(Cl)nn2c(cnc12)c3ccc4n[nH]cc4c3 | InChi: | InChI=1S/C16H15ClN6/c1-9(2)20-13-6-15(17)22-23-14(8-18-16(13)23)10-3-4-12-11(5-10)7-19-21-12/h3-9,20H,1-2H3,(H,19,21) | Definition date: | 2018-10-10 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 6-chloranyl-3-(2~{H}-indazol-5-yl)-~{N}-propan-2-yl-imidazo[1,2-b]pyridazin-8-amine |
|
| F2K | Name: | (5~{S})-7-azanyl-5-(4-chlorophenyl)-2,4-bis(oxidanylidene)-1,5-dihydropyrano[2,3-d]pyrimidine-6-carbonitrile | Formula: | C14 H9 Cl N4 O3 | SMILES: | NC1=C(C#N)[CH](c2ccc(Cl)cc2)C3=C(NC(=O)NC3=O)O1 | InChi: | InChI=1S/C14H9ClN4O3/c15-7-3-1-6(2-4-7)9-8(5-16)11(17)22-13-10(9)12(20)18-14(21)19-13/h1-4,9H,17H2,(H2,18,19,20,21)/t9-/m0/s1 | Definition date: | 2018-05-18 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | (5~{S})-7-azanyl-5-(4-chlorophenyl)-2,4-bis(oxidanylidene)-1,5-dihydropyrano[2,3-d]pyrimidine-6-carbonitrile |
|
| L9Y | Name: | 4-{[(2S)-2-butyl-6,7-dichloro-2-cyclopentyl-1-oxo-2,3-dihydro-1H-inden-5-yl]oxy}butanoic acid | Formula: | C22 H28 Cl2 O4 | SMILES: | CCCCC1(C(c2c(C1)cc(c(c2Cl)Cl)OCCCC(=O)O)=O)C3CCCC3 | InChi: | InChI=1S/C22H28Cl2O4/c1-2-3-10-22(15-7-4-5-8-15)13-14-12-16(28-11-6-9-17(25)26)19(23)20(24)18(14)21(22)27/h12,15H,2-11,13H2,1H3,(H,25,26)/t22-/m0/s1 | Definition date: | 2019-02-15 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 4-{[(2S)-2-butyl-6,7-dichloro-2-cyclopentyl-1-oxo-2,3-dihydro-1H-inden-5-yl]oxy}butanoic acid |
|
| GXK | Name: | 6-chloranyl-~{N}-(cyclopropylmethyl)-3-(2~{H}-indazol-5-yl)imidazo[1,2-b]pyridazin-8-amine | Formula: | C17 H15 Cl N6 | SMILES: | Clc1cc(NCC2CC2)c3ncc(n3n1)c4ccc5n[nH]cc5c4 | InChi: | InChI=1S/C17H15ClN6/c18-16-6-14(19-7-10-1-2-10)17-20-9-15(24(17)23-16)11-3-4-13-12(5-11)8-21-22-13/h3-6,8-10,19H,1-2,7H2,(H,21,22) | Definition date: | 2018-10-16 | Last modified: | 2019-02-22 | Release date: | 2019-02-27 | Identifier: | 6-chloranyl-~{N}-(cyclopropylmethyl)-3-(2~{H}-indazol-5-yl)imidazo[1,2-b]pyridazin-8-amine |
|